 |
 |
GEO help: Mouse over screen elements for information. |
|
| Status |
Public on Jun 09, 2010 |
| Title |
Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns |
| Organism |
Homo sapiens |
| Experiment type |
Methylation profiling by array
|
| Summary |
Introduction: Five different molecular subtypes of breast cancer have been identified through gene expression profiling. Each subtype has a characteristic expression pattern suggested to partly depend on cellular origin. We aimed to investigate whether the molecular subtypes also display distinct methylation profiles.
Methods: We analysed methylation status of 807 cancer-related genes in 189 fresh frozen primary breast tumours and four normal breast tissue samples using an array-based methylation assay.
Results: Unsupervised analysis revealed three groups of breast cancer with characteristic methylation patterns. The three groups were associated with the luminal A, luminal B and basal-like molecular subtypes of breast cancer, respectively, whereas cancers of the HER2-enriched and normal-like subtypes were distributed among the three groups. The methylation frequencies were significantly different between subtypes, with luminal B and basal-like tumours being most and least frequently methylated, respectively. Moreover, targets of the polycomb repressor complex in breast cancer and embryonic stem cells were more methylated in luminal B tumours than in other tumours. BRCA2-mutated tumours had a particularly high degree of methylation. Finally, by utilizing gene expression data, we observed that a large fraction of genes reported as having subtype-specific expression patterns might be regulated through methylation.
Conclusions: We have found that breast cancers of the basal-like, luminal A and luminal B molecular subtypes harbour specific methylation profiles. Our results suggest that methylation may play an important role in the development of breast cancers.
DNA methylation profiling of breast cancer samples and normal breast tissue samples. The Illumina GoldenGate Methylation Cancer Panel I was used to obtain DNA methylation profiles across approximately 1500 CpGs. Samples included 189 breast cancer samples and 4 normal breast tissue samples.
|
| |
|
| Overall design |
Bisulphite converted DNA from the samples were hybridised to the Illumina GoldenGate Methylation Cancer Panel I
|
| |
|
| Contributor(s) |
Holm K, Hegardt C, Staaf J, Vallon-Christersson J, Jönsson G, Olsson H, Borg A, Ringnér M |
| Citation(s) |
20565864 |
| |
| Submission date |
Jun 08, 2010 |
| Last update date |
Mar 22, 2012 |
| Contact name |
Johan Staaf |
| Organization name |
SCIBLU - Swegene Centre for Integrative Biology at Lund University
|
| Street address |
Medicon Village
|
| City |
Lund |
| ZIP/Postal code |
SE-223 81 |
| Country |
Sweden |
| |
|
| Platforms (1) |
| GPL9183 |
Illumina GoldenGate Methylation Cancer Panel I |
|
| Samples (193)
|
|
| Relations |
| BioProject |
PRJNA128879 |
| Supplementary file |
Size |
Download |
File type/resource |
| GSE22210_matrix_signal_intensities.txt.gz |
2.8 Mb |
(ftp)(http) |
TXT |
| Processed data not applicable for this record |
|
|
|
|
 |
Less...
More...